Tirzepatide Mechanism of Action: Dual Agonism in Metabolic Models

For laboratory research use only and by qualified professionals.

Tirzepatide has attracted significant interest in metabolic research as a dual agonist of GIP and GLP-1 receptors. This article details its pharmacological profile in laboratory models.

Receptor Binding

In adipocyte cultures, tirzepatide demonstrates high affinity for both receptors, producing balanced activation that differs from single-receptor agonists.

Signaling Pathways

Receptor activation triggers multiple intracellular cascades (cAMP, ERK1/2, β-arrestin) whose effects are being mapped in human adipocyte models.

In-Vitro Studies

Recent peer-reviewed publications highlight tirzepatide's ability to modulate lipid metabolism more effectively than older peptides in controlled in-vitro systems.

For laboratory research use only.

→ Tirzepatide Research Grade Peptide
→ Tirzepatide vs Semaglutide
→ Weight Loss Research Peptides

Author: Dr. Elena Voss, PhD Biochemistry – Senior Researcher, PenLab Peptide Research Division